Mobile Evidence-Based Smoking Cessation for Veterans Living With HIV (MESH)

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 18, 2019

Primary Completion Date

July 15, 2021

Study Completion Date

November 10, 2021

Conditions
Human Immunodeficiency VirusSmoking
Interventions
DRUG

Bupropion

Smoking cessation pharmacotherapy prescribed in accordance with package insert.

DRUG

Varenicline

Smoking cessation pharmacotherapy prescribed in accordance with package insert.

BEHAVIORAL

Cognitive Behavioral Therapy

Behavioral intervention; modules include identifying reasons for quitting, setting a quit date, breathing relaxation technique, identifying smoking triggers, identifying social support, and education about relapse prevention

DRUG

Nicotine Replacement Therapy

Participants may be prescribed single-formulation NRT (i.e., nicotine patch) or dual NRT (patch + rescue method such as nicotine gum, inhaler, or lozenges).

BEHAVIORAL

Relapse Prevention Text Messaging

Participants will be invited to utilize SmokefreeVET, a mobile text messaging service for military Veterans trying to quit smoking. The 6- to 8-week program provides 24/7 encouragement, advice, and tips to help smokers quit smoking and stay quit.

Trial Locations (1)

27705-3875

Durham VA Medical Center, Durham, NC, Durham

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT04135937 - Mobile Evidence-Based Smoking Cessation for Veterans Living With HIV (MESH) | Biotech Hunter | Biotech Hunter